Somebody Had a Good Quarter!

NxStage company revenues were up 7% in Q4 of 2013 over 2012, and annual revenue was up 9% in 2013 over 2012. In the home dialysis market, revenues rose by 12%—however, the net loss per share was $0.31 in 2013 vs. 0.26 in 2012.

Read the full article » | Posted 03-07-2014

Related Articles